References
- Criscitiello C, Fumagalli D, Saini KS, Loi S. Tamoxifen in early stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection. Onco. Targets Ther.4, 1–11 (2010).
- Nemunaitis J. Multifunctional vaccines in cancer: the ‘triad’ approach. Expert Rev. Vaccines10(6), 713–715 (2011).
- Mittendorf EA, Alatrash G, Xiao H, Clifton GT, Murray JL, Peoples GE. Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials. Expert Rev. Vaccines10(6), 755–774 (2011).
- Madan RA, Aragon-Ching JB, Gulley JL, Dahut WL. From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Rev. Vaccines10(6), 743–753 (2011).
- Leffers N, Daemen T, Boezen HM, Melief CJM, Nijman HW. Vaccine-based clinical trials in ovarian cancer. Expert Rev. Vaccines10(6), 775–784 (2011).
- Speetjens FM, Zeestraten ECM, Kuppen PJK, Melief CJM, van der Burg SH. Colorectal cancer vaccines in clinical trials. Expert Rev. Vaccines10(6), 899–921 (2011).
- Brookman-May S, Burger M, Wieland WF, Rößler W, May M, Denzinger S. Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease. Expert Rev. Vaccines10(6), 837–852 (2011).
- Plate J. Clinical trials of vaccines for immunotherapy in pancreatic cancer. Expert Rev. Vaccines10(6), 825–836 (2011).
- Rossi A, Maione P, Schettino C et al. Non-small-cell lung carcinoma vaccines in clinical trials. Expert Rev. Vaccines10(6), 887–897 (2011).
- Casalegno-Garduño R, Schmitt A, Schmitt M. Clinical peptide vaccination trials for leukemia patients. Expert Rev. Vaccines10(6), 785–799 (2011).
- Inogés S, López-Díaz de Cerio A, Villanueva H, Soria E, Pastor F, Bendandi M. Idiotype vaccines for lymphoma therapy. Expert Rev. Vaccines10(6), 801–809 (2011).
- Klein O, Schmidt C, Knights A, Davis ID, Chen W, Cebon J. Melanoma vaccines: developments over the past 10 years. Expert Rev. Vaccines10(6), 853–873 (2011).
- Bridle BW. Neuroendocrine cancer vaccines in clinical trials. Expert Rev. Vaccines10(6), 811–823 (2011).
- Wheeler CJ, Black KL. Vaccines for glioblastoma and high-grade glioma. Expert Rev. Vaccines10(6), 875–886 (2011).
- See AP, Pradilla G, Yang I, Han S, Parsa AT, Lim M. Heat shock protein–peptide complex (HSPPC-96, prophage, oncophage, vitespen) in the treatment of glioblastoma. Expert Rev. Vaccines10(6), 721–732 (2011).
- Morse M, Bradley DA, Keler T et al. CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer. Expert Rev. Vaccines10(6), 733–742 (2011).
Website
- How to prevent cancer http://mywaytohealth.com/How%20to%20prevent%20Cancer.html